Patrick Ramiah

Patrick Ramiah leads the delivery of clinical studies and drives operational excellence across the organisation. He is responsible for ensuring clinical projects are delivered on time, in full and to the highest standards of quality, while maintaining patient safety as the organisation's foremost priority. Working closely with multidisciplinary teams, Patrick oversees project governance, operational performance and continuous improvement to enable efficient, compliant and high-quality clinical research delivery.

A Lean Six Sigma Master Black Belt with more than 22 years of experience in operational excellence and organisational transformation, Patrick has championed Richmond's adoption of Lean Six Sigma principles to strengthen a culture of continuous improvement. He has led initiatives that optimise end-to-end workflows, improve cross-functional collaboration, enhance project governance and translate strategic objectives into practical, sustainable ways of working. His leadership combines data-driven decision-making with hands-on coaching, empowering teams to consistently improve performance, efficiency and quality.

Since joining Richmond in 2023, Patrick has played a key role in strengthening organisational capability through clinical project optimisation, performance management and operational governance. His work focuses on risk-based planning, robust project controls, clearly defined accountability and meaningful performance metrics that support proactive decision-making and successful project execution throughout the clinical study lifecycle.

Patrick is passionate about building scalable, resilient systems that improve organisational capability, strengthen regulatory compliance and enable Richmond Pharmacology to deliver safe, efficient and high-quality clinical research. His approach places equal emphasis on operational excellence, people engagement and sustainable capability building, ensuring improvements become embedded within the organisation and continue to deliver long-term value for sponsors, patients and the wider clinical research community.

‍